Cargando…

Signalling Alterations in Bones of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Gene Deficient Mice

Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide with diverse developmental roles, including differentiation of skeletal elements. It is a positive regulatory factor of chondrogenesis and osteogenic differentiation in vitro, but little is known about its in vivo role in b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Józsa, Gergő, Szegeczki, Vince, Pálfi, Andrea, Kiss, Tamás, Helyes, Zsuzsanna, Fülöp, Balázs, Cserháti, Csaba, Daróczi, Lajos, Tamás, Andrea, Zákány, Róza, Reglődi, Dóra, Juhász, Tamás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163297/ https://www.ncbi.nlm.nih.gov/pubmed/30150589 http://dx.doi.org/10.3390/ijms19092538

Ejemplares similares

Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
por: Józsa, Gergő, et al.
Publicado: (2019)

Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
por: Szegeczki, Vince, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Reduces Oxidative and Mechanical Stress-Evoked Matrix Degradation in Chondrifying Cell Cultures
por: Szentléleky, Eszter, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Pathway Is Induced by Mechanical Load and Reduces the Activity of Hedgehog Signaling in Chondrogenic Micromass Cell Cultures
por: Juhász, Tamás, et al.
Publicado: (2015)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Signalling Exerts Chondrogenesis Promoting and Protecting Effects: Implication of Calcineurin as a Downstream Target
por: Juhász, Tamás, et al.
Publicado: (2014)

Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice
por: Fulop, Daniel Balazs, et al.
Publicado: (2019)

Intestinal Microbiota Changes in Mice Lacking Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) – Bifidobacteria Make the Difference
por: Heimesaat, Markus M., et al.
Publicado: (2017)

Physical Activity Protects the Pathological Alterations of Alzheimer’s Disease Kidneys via the Activation of PACAP and BMP Signaling Pathways
por: Perényi, Helga, et al.
Publicado: (2020)

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
por: Kasica, Natalia, et al.
Publicado: (2016)

Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models
por: Maasz, Gabor, et al.
Publicado: (2017)

Kynurenic Acid Inhibits the Electrical Stimulation Induced Elevated Pituitary Adenylate Cyclase-Activating Polypeptide Expression in the TNC
por: Körtési, Tamás, et al.
Publicado: (2018)

Pituitary Adenylate Cyclase Activating Polypeptide Has Inhibitory Effects on Melanoma Cell Proliferation and Migration In Vitro
por: Hajdú, Tibor, et al.
Publicado: (2021)

Alzheimer’s Disease Mouse as a Model of Testis Degeneration
por: Szegeczki, Vince, et al.
Publicado: (2020)

Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach
por: Reglodi, Dora, et al.
Publicado: (2018)

Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model
por: Botz, Bálint, et al.
Publicado: (2014)

Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney
por: Horvath, Gabriella, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
por: Tóth, Dénes, et al.
Publicado: (2023)

Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018)

Physical Training Inhibits the Fibrosis Formation in Alzheimer’s Disease Kidney Influencing the TGFβ Signaling Pathways
por: Szegeczki, Vince, et al.
Publicado: (2021)

Corrigendum: Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson’s disease focusing on correlations with motor symptoms
por: Pham, Daniel, et al.
Publicado: (2022)

Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome
por: Eneman, Benedicte, et al.
Publicado: (2017)

Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice
por: Hattori, Satoko, et al.
Publicado: (2012)

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus
por: Johnson, Gregory C., et al.
Publicado: (2020)

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits
por: Ciranna, Lucia, et al.
Publicado: (2021)

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
por: Horvath, Gabriella, et al.
Publicado: (2022)

Pituitary Adenylate Cyclase-Activating Polypeptide Ameliorates Experimental Acute Ileitis and Extra-Intestinal Sequelae
por: Heimesaat, Markus M., et al.
Publicado: (2014)

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)

Pituitary adenylate cyclase-activating polypeptide (PACAP) acts in the nucleus accumbens to reduce hedonic drive
por: Hurley, Matthew M., et al.
Publicado: (2018)

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Protective Effects of PACAP in a Rat Model of Diabetic Neuropathy
por: Kiss, Peter, et al.
Publicado: (2021)

Pituitary Adenylate Cyclase-Activating Polypeptide—A Neuropeptide as Novel Treatment Option for Subacute Ileitis in Mice Harboring a Human Gut Microbiota
por: Bereswill, Stefan, et al.
Publicado: (2019)

Accelerated pre‐senile systemic amyloidosis in PACAP knockout mice – a protective role of PACAP in age‐related degenerative processes
por: Reglodi, Dora, et al.
Publicado: (2018)

VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice
por: Ivic, Ivan, et al.
Publicado: (2019)

SUN-484 Effect of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Regulation of Hypothalamic Kisspeptin Expression
por: Kanasaki, Haruhiko, et al.
Publicado: (2019)

Relationship between Plasma Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Level and Proteome Profile of Cows
por: Czegledi, Levente, et al.
Publicado: (2022)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma
por: Patko, Evelin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gtcg3s7t4aaro4vr74ihjpcn0n